Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Magazines
Fall Home Improvements
Women
Home & Realty
Outdoor Guide
Premier Home Style Tour 2024
Spring Home & Garden Show
Spring on the Road
Spring Wellness
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
Parcel Pickup
2024 Readersâ Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Evaxion Biotech A/S ADR
(NQ:
EVAX
)
1.140
-0.050 (-4.20%)
Streaming Delayed Price
Updated: 3:59 PM EST, Dec 13, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Evaxion Biotech A/S ADR
< Previous
1
2
3
4
5
6
7
Next >
12 Health Care Stocks Moving In Thursday's Pre-Market Session
December 12, 2024
Via
Benzinga
Evaxion announces business update and third quarter 2024 financial results
October 31, 2024
From
Evaxion Biotech
Via
GlobeNewswire
Evaxion Biotech Partners With Merck To Expand Vaccine Development
September 26, 2024
Evaxion Biotech enters an expanded collaboration with Merck, granting an option to license preclinical vaccine candidates. The deal includes $3.2 million upfront and potential earnings up to $592...
Via
Benzinga
Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing
September 20, 2024
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com
From
Virtual Investor Conferences
Via
GlobeNewswire
Recap: Evaxion Biotech Q4 Earnings
March 27, 2024
Via
Benzinga
Life Sciences Virtual Investor Forum Agenda Announced for September 19th
September 16, 2024
Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com
From
Virtual Investor Conferences
Via
GlobeNewswire
EVAX Stock Earnings: Evaxion Biotech Beats EPS, Beats Revenue for Q2 2024
August 14, 2024
EVAX stock results show that Evaxion Biotech beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via
InvestorPlace
Evaxion Announces Business Update and Second Quarter 2024 Financial Results
August 14, 2024
From
Evaxion Biotech
Via
GlobeNewswire
iAccess Alpha's Buyside Best Ideas Virtual Summer Conference June 25-26, 2024
June 21, 2024
Via
ACCESSWIRE
12 Health Care Stocks Moving In Wednesday's After-Market Session
June 19, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
June 18, 2024
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
June 17, 2024
Via
Benzinga
EVAX Stock Earnings: Evaxion Biotech Beats EPS, Beats Revenue for Q1 2024
May 28, 2024
EVAX stock results show that Evaxion Biotech beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via
InvestorPlace
Evaxion Announces Business Update and First Quarter 2024 Financial Results
May 28, 2024
From
Evaxion Biotech
Via
GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Intraday Session
April 02, 2024
Via
Benzinga
Evaxion and Undisclosed Collaborator Announce Encouraging Results for EVX-B1 Vaccine Antigens Against Staphylococcus Aureus Infection
April 02, 2024
From
Evaxion Biotech
Via
GlobeNewswire
EVAX Stock Earnings: Evaxion Biotech Meets EPS for Q4 2023
March 27, 2024
EVAX stock results show that Evaxion Biotech met analyst estimates for earnings per share the fourth quarter of 2023.
Via
InvestorPlace
Evaxion Announces Business Update and Full Year 2023 Financial Results
March 27, 2024
From
Evaxion Biotech
Via
GlobeNewswire
Evaxion Hosts R&D Day and Unveils the Broad Potential of Its AI-Immunology™ Platform
March 19, 2024
From
Evaxion Biotech
Via
GlobeNewswire
Evaxion to Host R&D Day on March 19, 2024, Highlighting its Latest Technology Innovations
February 29, 2024
From
Evaxion Biotech
Via
GlobeNewswire
Evaxion Announces Successful Completion of the Initial Phases of Ongoing Vaccine Collaboration with MSD
February 20, 2024
From
Evaxion Biotech
Via
GlobeNewswire
Evaxion Regains Compliance with Nasdaq Minimum Bid Price Requirement
February 07, 2024
From
Evaxion Biotech
Via
GlobeNewswire
Evaxion Announces Closing of $15 Million Public Offering
February 06, 2024
From
Evaxion Biotech
Via
GlobeNewswire
Why C.H. Robinson Shares Are Trading Lower By Over 12%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
February 01, 2024
Shares of C.H. Robinson Worldwide, Inc. (NASDAQ: CHRW) fell sharply during Thursday’s session after the company reported worse-than-expected fourth-quarter financial results.
Via
Benzinga
Evaxion Biotech Announces Pricing of $15 Million Public Offering
February 01, 2024
From
Evaxion Biotech
Via
GlobeNewswire
Why AMD Shares Are Trading Lower? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
January 31, 2024
Shares of Advanced Micro Devices, Inc. (NASDAQ: AMD) shares declined 3.8% to $165.49 following fourth-quarter results. AMD reported fourth-quarter non-GAAP earnings per share of 77 cents per share on...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
January 31, 2024
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
January 26, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
January 25, 2024
Via
Benzinga
Dow Edges Lower; US Composite PMI Rises In January
January 24, 2024
U.S. stocks traded mixed toward the end of trading, with the Dow Jones index turning lower on Wednesday. The Dow traded down 0.05% to 37,886.62 while the NASDAQ rose 0.59% to 15,517.32. The S&P 500...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.